What we publish, and whether you fit
Clinical and translational neurology, from epilepsy and neurodegeneration to stroke and neurocritical care, with case reports actively welcomed. Check your fit in about 30 seconds.
Neurology research, reviewed quickly and carefully
The Journal of Neurological Research and Therapy publishes clinical and translational neurology that informs patient care: from mechanism and biomarker through to therapy and outcome. We cover epilepsy, neurodegeneration, multiple sclerosis and neuroimmunology, stroke and neurovascular disease, neurotrauma and neurocritical care, and clinical neurophysiology. We give that work a fast, citable, open-access route to the neurologists, clinicians and researchers who put it to use, and we actively welcome well-documented neurological case reports.
Is your study in scope?
If it sits on the left, you are in the right place. If it sits on the right, we will likely redirect it, so you can save yourself a review cycle.
In scope
- Clinical and translational neurology with a patient or mechanism-to-therapy focus
- Epilepsy and antiepileptic therapy; neurodegeneration (ALS / motor neuron disease, Parkinson's, dementia, Alzheimer's)
- Multiple sclerosis and neuroimmunology; stroke and neurovascular disease; neurotrauma and neurocritical care
- Clinical neurophysiology, and well-documented neurological case reports and case series
Out of scope
- Animal-only or in-vitro studies with no clinical or translational link to human neurology
- Sports, exercise or turf-performance science without a neurological question
- Topics outside neurology (general internal medicine, oncology, cardiology) with no neurological focus
- Opinion pieces without data, methods or a documented clinical case
The work we publish
These are the areas where most accepted JNRT papers sit. Each “typical fit” reflects the kind of study we genuinely publish.
Epilepsy and Seizure Disorders
- Antiepileptic drug therapy and treatment response
- Drug-resistant and refractory epilepsy
- EEG and seizure semiology
- Epilepsy in special populations
Neurodegeneration
- ALS and motor neuron disease
- Parkinson's disease and movement disorders
- Dementia and Alzheimer's disease
- Disease biomarkers and progression
Multiple Sclerosis and Neuroimmunology
- Multiple sclerosis diagnosis and management
- Disease-modifying therapy outcomes
- Neuroinflammation and autoimmune neurology
- Immune biomarkers
Stroke and Neurovascular Disease
- Acute ischaemic and haemorrhagic stroke
- Reperfusion and secondary prevention
- Cerebrovascular imaging and risk
- Post-stroke recovery
Neurotrauma and Neurocritical Care
- Traumatic brain and spinal cord injury
- Neurocritical care management
- Intracranial pressure and monitoring
- Outcome prediction
Clinical Neurophysiology and Case Reports
- EEG, EMG and evoked-potential studies
- Electrophysiology of neural and retinal function
- Well-documented neurological case reports
- Instructive case series
Scope is limited to neurology. For how to prepare a submission by article type, see the Instructions for Authors.
If you fit, here is why authors choose us
A fast, fair, fully open-access home for neurology research, built around what working clinicians and researchers actually need.
A named neurology board
Every decision on your manuscript is signed by a named editor in the relevant field, supported by an international board of clinicians and researchers.
A fast first decision
We aim for a first decision in about three weeks, with acknowledgement of your submission within 72 hours, so your work does not sit in silence.
Open access with a DOI
Articles publish open access under a Creative Commons CC BY licence, each with a permanent Crossref DOI that is citable from day one.
Case reports are welcomed
Well-documented neurological case reports and case series are a genuine part of what we publish, not an afterthought, when they carry clear, generalisable learning.
Discoverable, not paywalled
Your article is discoverable in Google Scholar and via OpenAlex (ISSN 2470-5020), reaching neurologists and researchers without a paywall in the way.
Transparent pricing
A single article processing charge of $2,100 applies only on acceptance. There is no fee to submit or to be reviewed.
Explicitly out of scope
We are upfront about what we decline, so you do not lose time on a manuscript we cannot consider.
Non-clinical animal or in-vitro work
Studies confined to animal models or cell systems with no clinical or translational link to human neurology. A mechanistic study that explicitly bears on a human neurological disease can fit.
Performance or sports science
Sports, exercise and turf-performance science that does not pose a neurological question. Work on neurotrauma or concussion with a clear clinical neurology focus is in scope.
Topics outside neurology
General internal medicine, oncology or cardiology submissions without a neurological focus. If the neurological angle is central and documented, the work may fit.
Not sure if you fit?
Send a working title and short abstract and we will tell you whether your study is in scope before you prepare a full submission. It saves everyone a review cycle.
Frequently asked
How do I know if my study is in scope?
What subjects does the journal cover?
Do you publish case reports?
Do you accept animal or laboratory studies?
Are systematic reviews and meta-analyses welcome?
Do you publish clinical trials, and is registration required?
Is stroke and neurovascular research in scope?
Do you consider neurodegeneration research (ALS, Parkinson's, dementia)?
Are multiple sclerosis and neuroimmunology in scope?
Do you cover clinical neurophysiology?
What about neurotrauma and neurocritical care?
Are null or negative results considered?
Is sports or performance science in scope?
I am not sure my topic fits. Can I check first?
A good fit? We would like to see your work
If your research advances clinical or translational neurology, read the author guidelines and submit through ManuscriptZone, or ask us first if you are unsure.